Lauren M Holland, MD
Obstetrics/Gynecology · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Holland’s office at (408) 871-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A93009 · Current
Licensed to practise in California · since 2005 · expires 2027-01-31 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$0 in 2024
Medicaid paid $0 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TOBACCO NON-USER | 13 | $0 |
| 2024 | 13 | 1 | 12 | $0 |
Drugs they prescribed that Part D paid
$27,689
Pharmacies billed $27,689 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 300) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
260 generic and 40 brand-name prescriptions · $27,689 in drug cost · 23 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estring | 17 | $10,400 | $612 |
| Yuvafem | 26 | $2,789 | $107 |
| Estradiol | 64 | $2,736 | $43 |
| Climara | 13 | $1,814 | $140 |
| Trospium Chloride | 22 | $1,271 | $58 |
See all 9 drugs
| Estring | 17 | $10,400 | $612 |
| Yuvafem | 26 | $2,789 | $107 |
| Estradiol | 64 | $2,736 | $43 |
| Climara | 13 | $1,814 | $140 |
| Trospium Chloride | 22 | $1,271 | $58 |
| Dotti | 11 | $1,010 | $92 |
| Acyclovir | 17 | $302 | $18 |
| Clobetasol Propionate | 15 | $229 | $15 |
| Triamcinolone Acetonide | 11 | $94 | $9 |
Year by year
| 2024 | 300 | 160 | 0% (0) | 13% | $27,689 |
| 2023 | 253 | 119 | 0% (0) | 19% | $23,267 |
| 2022 | 249 | 109 | 0% (0) | 10% | $18,326 |
| 2021 | 176 | 83 | 0% (0) | 11% | $14,553 |
| 2020 | 177 | 68 | None | 11% | $14,097 |
| 2019 | 135 | 53 | 0% (0) | 18% | $12,417 |
| 2018 | 117 | 51 | 0% (0) | 32% | $13,922 |
| 2017 | 130 | 54 | 0% (0) | 31% | $18,775 |
| 2016 | 144 | 59 | 0% (0) | 41% | $18,422 |
| 2015 | 152 | 65 | 0% (0) | 33% | $19,975 |
| 2014 | 125 | 56 | 0% (0) | 23% | $9,108 |
| 2013 | 61 | 31 | 0% (0) | 49% | $4,928 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Estring | 12 | $7,133 | $594 |
| Climara | 17 | $2,468 | $145 |
| Estradiol | 54 | $2,112 | $39 |
| Yuvafem | 15 | $1,793 | $120 |
| Trospium Chloride | 22 | $963 | $44 |
| Nystatin-Triamcinolone | 12 | $356 | $30 |
| Acyclovir | 13 | $279 | $21 |
| Triamcinolone Acetonide | 11 | $108 | $10 |
2022: 5 drugs
| Yuvafem | 16 | $2,385 | $149 |
| Estradiol | 63 | $2,169 | $34 |
| Trospium Chloride | 28 | $1,553 | $55 |
| Acyclovir | 18 | $529 | $29 |
| Medroxyprogesterone Acetate | 16 | $226 | $14 |
2021: 3 drugs
| Estradiol | 61 | $3,746 | $61 |
| Yuvafem | 11 | $1,611 | $146 |
| Trospium Chloride | 12 | $848 | $71 |
2020: 2 drugs
| Estradiol | 63 | $5,000 | $79 |
| Medroxyprogesterone Acetate | 11 | $220 | $20 |
2019: 3 drugs
| Estradiol | 40 | $1,789 | $45 |
| Trospium Chloride | 14 | $708 | $51 |
| Medroxyprogesterone Acetate | 12 | $254 | $21 |
2018: 3 drugs
| Estrace | 22 | $2,606 | $118 |
| Estradiol | 22 | $749 | $34 |
| Medroxyprogesterone Acetate | 14 | $385 | $28 |
2017: 4 drugs
| Estrace | 17 | $5,242 | $308 |
| Premarin | 11 | $3,268 | $297 |
| Estradiol | 31 | $832 | $27 |
| Medroxyprogesterone Acetate | 12 | $366 | $30 |
2016: 3 drugs
| Premarin | 21 | $5,760 | $274 |
| Estradiol | 22 | $696 | $32 |
| Fluconazole | 17 | $129 | $8 |
2015: 4 drugs
| Estrace | 19 | $4,594 | $242 |
| Premarin | 19 | $4,453 | $234 |
| Estradiol | 24 | $625 | $26 |
| Acyclovir | 11 | $242 | $22 |
2014: 2 drugs
| Nystatin-Triamcinolone | 14 | $1,094 | $78 |
| Estradiol | 29 | $523 | $18 |
2013: 1 drug
| Estradiol | 11 | $377 | $34 |
Money from drug and device companies
$16 in 2025
A payment is not proof that care is biased.
| Motiva USA | Motiva Implant Matrix | $16 | 1 payment
|
See the published payment
| Motiva USA | Meals · 2025-05-06 | Motiva Implant Matrix | $16 |
Professional record
- NPI
- 1922155670
- Licence
- CA A93009California A93009: Current · expires 2027-01-31
- Trained
- Loyola University of Chicago, Stritch School of Medicine, 2004
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 220 E Hacienda Ave, Campbell, CA, 95008
- NPI first listed
- 2007-01-04
- NPI last updated
- 2021-12-14
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.